SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Lewis AJ. Melancholia: a historical review. J Ment Sci 1934; 80: 142.
  • 2
    Barraclough B. Suicide and epilepsy. In: ReynoldsFH, TrimbleMR, eds. Epilepsy and psychiatry. Edinburgh : Churchill-Livingstone, 1981: 726.
  • 3
    Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997; 170: 20528.
  • 4
    Robertson MM. Suicide, parasuicide, and epilepsy. In: EngelJJr, PedleyTA, eds. Epilepsy: a comprehensive textbook. Philadelphia : Lippincott-Raven, 1997.
  • 5
    Mackay A. Self-poisoning: a complication of epilepsy. Br J Psychiatry 1979; 34: 27782.
  • 6
    Hawton K, Fagg J, Marsack P. Association between epilepsy and attempted suicide. J Neurol Neurosurg Psychiatry 1980; 43: 16870.
  • 7
    Blumer D, Benson DF. Psychiatric manifestations of epilepsy. In: BensonDF, BlumerD, eds. Psychiatric Aspects of Neurological Disease, Vol II. New York : Grune and Stratton, 1982; 2548.
  • 8
    Taylor DC, Marsh SM. Implications of long-term follow-up studies in epilepsy: with a note on the cause of death. In: PenryJK, ed. Epilepsy: The 8th International Symposium. New York : Raven Press, 1977: 2734.
  • 9
    Jensen I, Larsen JK. Mental aspects of temporal lobe epilepsy, follow-up of 74 patients after resection of a temporal lobe. J Neurol Neurosurg Psychiatry 1979; 42: 25665.
  • 10
    Obafunwa JO, Busuttil A. Clinical contact preceding suicide. Postgrad Med J 1994; 70: 42832.
  • 11
    Devinsky O, Bear DM. Varieties of depression in epilepsy. Neuropsychiatry Neuropsychol Behav Neurol 1991; 4: 4961.
  • 12
    Grule HW. Epileptische Reaktionen und epileptische Krankheiten. In: BumkeO, ed. Handbuch der Geistenkrankheiten. Vol. 18. Spezieller Teil 4. Berlin : Springer, 1930: 669728.
  • 13
    Blanchet P, Frommer GP. Mood change preceding epileptic seizures. J Nerv Ment Dis 1986; 174: 4716.
  • 14
    Hughes J, Devinsky O, Feldmann E, Bromfield E. Premonitory symptoms in epilepsy seizure. 1993; 2: 2013.
  • 15
    Williams D. The structure of emotions reflected in epileptic experiences. Brain 1956; 79: 2967.
  • 16
    Weil AA. Ictal emotions occurring in temporal lobe dysfunction. Arch Neurol 1959; 1: 8797.
  • 17
    Devinsky O, Feldmann E, Bromfield E, Emoto S, Raubertis R. Structured interview for simple partial seizures: clinical phenomenology and diagnosis. J Epilepsy 1991; 4: 10716.
  • 18
    Lim J, Yagnik P, Schraeder P, Wheeler S. Ictal catatonia as a manifestation of nonconvulsive status epilepticus. J Neurol Neurosurg Psychiatry 1986; 49: 8336.
  • 19
    Betts TA. Neuropsychiatry. In: LaidlawJ, RichensA, ChadwickD, eds. A textbook of epilepsy. 4th ed. Edinburgh : Churchill-Livingstone, 1993: 397458.
  • 20
    Mendez MF, Doss RC. Ictal and psychiatric aspects of suicide in epileptic patients. Int J Psychiatry Med 1992; 22: 2317.
  • 21
    Gillham RA. Refractory epilepsy: an evaluation of psychological methods in outpatient management. Epilepsia 1990; 31: 42732.
  • 22
    Betts T, Fox C, MacCallum R. Using olfactory stimuli to abort or prevent seizures: Countermeasures or cue-controlled arousal manipulation? Is there something special about smell? [Abstract]. Epilepsia 1995; 36 (suppl 3): S25.
  • 23
    Goldstein LH. Effectiveness of psychological interventions for people with poorly controlled epilepsy. J Neurol Neurosurg Psychiatry 1997; 63: 13743.
  • 24
    Blumer D. Posticlal depression: significance for the neurobehavioral disorder of epilepsy. J Epilepsy 1992; 5: 2149.
  • 25
    Devinsky O, Kelley K, Yacubian EMT, Sato S, Kufta CV, Theodore WH. Postictal behavior. A clinical and subdural electroen-cephalographic study. Arch Neurol 1994; 51: 2549.
  • 26
    Hurwitz TA, Wada JA, Kosaka BD, Strauss EH. Cerebral organization of affect suggested by temporal lobe seizures. Neurology 1985; 35: 13357.
  • 27
    Currie S, Heathfield W, Henson R, Scott D. Clinical course and prognosis of temporal lobe epilepsy: a survey of 666 patients. Brain 1971; 94: 17390.
  • 28
    Taylor DC. Mental state and temporal lobe epilepsy, a correlative account of 100 patients treated surgically. Epilepsia 1972; 13: 72765.
  • 29
    Standage KF, Fenton GW. Psychiatric symptom profiles of patients with epilepsy: a controlled investigation. Psychol Med 1975; 5: 15260.
  • 30
    Roy A. Some determinants of affective symptoms in epileptics. Can J Psychiatry 1979; 24: 5546.
  • 31
    Mendez MF, Cummings JL, Benson DF. Depression in epilepsy. Significance and phenomenology. Arch Neurol 1986; 43: 76670.
  • 32
    Brown SW, McGowan MEL, Reynolds EH. The influence of seizure type and medication on psychiatric symptoms in epileptic patients. Br J Psychiatry 1986; 148: 3004.
  • 33
    Edeh J, Toone B. Relationship between interictal psychopathology and type of epilepsy. Results of a survey in general practice. Br J Psychiatry 1987; 151: 95101.
  • 34
    Edeh J, Toone BK, Corney RH. Epilepsy, psychiatric morbidity, and social dysfunction in general practice. Comparison between clinic patients and clinic nonattenders. Neuropsychiatry Neuropsychol Behav Neurol. 1990; 3: 18092.
  • 35
    Victoroff JI, Benson DF, Engel J Jr, Grafton S, Mazziotta JC. Interictal depression in patients with medically intractable complex partial seizures: electroencephalography and cerebral metabolic correlates [Abstract]. Ann Neurol 1990; 28: 221.
  • 36
    Gureje O. Interictal psychopathology in epilepsy. Prevalence and pattern in a Nigerian clinic. Br J Psychiatry 1991; 158: 7005.
  • 37
    Indaco A, Carrieri PB, Nappi C, Gentile S, Striano S. Interictal depression in epilepsy. Epilepsy Res 1992; 12: 4550.
  • 38
    Victoroff JI, Benson DF, Grafton ST, Engel J Jr, Mazziotta JC. Depression in complex partial seizures. Electroencephalography and cerebral metabolic correlates. Arch Neurol 1994; 51: 15563.
  • 39
    Robertson MM, Channon S, Baker J. Depressive symptomatology in a general hospital sample of outpatients with temporal lobe epilepsy: a controlled study. Epilepsia 1994; 35: 7717.
  • 40
    Manchanda R, Schaefer B, McLachlan RS, et al. Psychiatric disorders in candidates for surgery for epilepsy. J Neurol Neurosurg Psychiatry 1996; 61: 829.
  • 41
    Jacoby A, Baker GA, Steen N, Potts P, Chadwick DW. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. community study. Epilepsia 1996; 37: 14861.
  • 42
    Baker GA, Jacoby A, Chadwick DW. The associations of psychopathology in epilepsy: a community study. Epilepsy Res 1996; 25: 2939.
  • 43
    Ring HA, Moriarty J, Trimble MR. A prospective study of the early postsurgical psychiatric associations of epilepsy surgery. J Neurol Neurosurg Psychiatry 1998; 64: 6014.
  • 44
    Blumer D, Wakhlu S, Davies K, Hermann B. Psychiatric outcome of temporal lobectomy for epilepsy: incidence and treatment of psychiatric complications. Epilepsia 1998; 39: 47886.
  • 45
    Boyd JH, Weissman MM. Epidemiology. In: PaykelES, ed. Handbook of Affective Disorders. New York : The Guildford Press, 1982; 10925.
  • 46
    Kogeorgos J, Fonagy P, Scott DF. Psychiatric symptom patterns of chronic epileptics attending a neurological clinic: a controlled investigation. Br J Psychiatry 1982; 140: 23643.
  • 47
    Mendez MF, Doss RC, Taylor JL, Salguero P. Depression in epilepsy. Relationship to seizures and anticonvulsant therapy. J Nerv Ment Dis 1993; 181: 4447.
  • 48
    Pond D, Bidwell B, Stein L. A survey of 14 general practices. Part I: Medical and demographic data. Psychiatr Neurol Neurochir 195960; 63: 21736.
  • 49
    Trostle JA, Hauser A, Sharbrough FW. Psychologic and social adjustment to epilepsy in Rochester, Minnesota. Neurology 1989; 39: 6337.
  • 50
    Fiordelli E, Beghi E, Bogliun G, Crespi V. Epilepsy and psychiatric disturbance. A cross-sectional study. Br J Psychiatry 1993; 163: 44650.
  • 51
    Altshuler LL, Devinsky O, Post RM, Theodore W. Depression, anxiety, and temporal lobe epilepsy. Laterality of focus and symptoms. Arch Neurol 1990; 47: 2848.
  • 52
    Strauss E, Wada J, Moll A. Depression in male and female subjects with complex partial seizures. Arch Neurol 1992; 49: 3912.
  • 53
    Septien L, Grass P, Giroud M, et al. Depression and temporal lobe epilepsy: the possible role of laterality of the epileptic foci and gender. Neurophysiol Clin 1993; 23: 3267.
  • 54
    Robertson MM, Trimble MR, Townsend HRA. Phenomenology of depression in epilepsy. Epilepsia 1987; 28: 36472.
  • 55
    Hermann BP, Whitman S. Psychosocial predictors of interictal depression. J Epilepsy 1989; 2: 2317.
  • 56
    Robertson MM. Depression in neurological disorders. In: RobertsonMM, KatonaCLE, eds. Depression and physical illness. Chichester : John Wiley, 1997: 30540.
  • 57
    Lishman WA. Organic psychiatry. The psychological consequences of cerebral disorder. 3rd ed. Oxford : Blackwell Science, 1998.
  • 58
    Koch-Weser M, Garron DC, Gilley DW, et al. Prevalence of psychologic disorders after surgical treatment of seizures. Arch Neurol 1988; 45: 130811.
  • 59
    Hermann BP, Wyler AR. Depression, locus of control, and the effects of epilepsy surgery. Epilepsia 1989; 30: 3328.
  • 60
    Murray RE, Abou-Khalil B, Griner L. Evidence for familial association of psychiatric disorders and epilepsy. Biol Psychiatry 1994; 36: 4289.
  • 61
    Thompson PJ, Oxley J. Socioeconomic accompaniments of severe epilepsy. Epilepsia 1988; 29 (suppl 1): S918.
  • 62
    Lund J. Epilepsy and psychiatric disorder in the mentally retarded adult. Acta Psychiatr Scand 1985; 72: 55762.
  • 63
    Steffenberg S, Gillberg C, Steffenberg U. Psychiatric disorders in children and adolescents with mental retardation and active epilepsy. Arch Neurol 1996; 53: 90412.
  • 64
    Deb S, Hunter D. Psychopathology of people with mental handicap and epilepsy II: Psychiatric illness. Br J Psychiatry 1991; 159: 82630.
  • 65
    Pary R. Mental retardation, mental illness, and seizure diagnosis. Am J Ment Retard 1993; 98: S5862.
  • 66
    Meldrum BS. Neurochemical substrates of ictal behavior. In: SmithDB, TreimanDM, eds. Neurobehavioral problems in epilepsy. (Advances in neurology, vol 55). New York : Raven Press, 1991: 3545.
  • 67
    Mignone RJ, Dannelly EF, Sadowsky D. Psychological and neurological comparisons of psychomotor and non-psychomotor epileptic patients. Epilepsia 1970; 11: 34559.
  • 68
    Deleted in proof.
  • 69
    Dikmen S, Hermann BP, Witensky AJ, Rainwater G. Validity of the Minnesota Multiphasic Personality Inventory (MMPI) to psychopathology in patients with epilepsy. J Nerv Ment Dis 1983; 171: 11422.
  • 70
    Dodrill CB, Batzel LW. Inter-ictal behavioural features of patients with epilepsy. Epilepsia 1986; 27 (suppl 2): S6476.
  • 71
    Gibbs FA. Ictal and non-ictal psychiatric disorders in temporal lobe epilepsy. J Nerv Ment Dis 1951; 51: 5228.
  • 72
    Dongier S. Statistical study of clinical and electroencephalo-graphic manifestations of 536 psychotic episodes occurring in 516 epileptics between clinical seizures. Epilepsia 195960; 1: 11742.
  • 73
    Rodin EA, Rim CS, Kitano H, et al. A comparison of the effectiveness of primidone versus carbamazepine in epileptic outpatients. J Nerv Ment Dis 1976; 163: 416.
  • 74
    Perini GI, Tosin C, Carraro C, et al. Interictal mood and personality disorders in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 1996; 61: 6015.
  • 75
    Small JG, Milstein V, Stevens JR. Are psychomotor epileptics different? A controlled study. Arch Neurol 1962; 7: 18794.
  • 76
    Stevens JR. Psychiatric implications of psychomotor epilepsy. Arch Gen Psychiatry 1966; 14: 46171.
  • 77
    Hermann BP, Seidenberg M, Haltiner A, Wyler AR. Mood state in unilateral temporal lobe epilepsy. Biol Psychiatry 1991; 30: 120518.
  • 78
    Bromfield EB, Altshuler L, Leiderman DB, et al. Cerebral metabolism and depression in patients with complex partial seizures. Arch Neurol 1992; 49: 61723.
  • 79
    Trimble M, Perez M. The phenomenology of the chronic psychoses of epilepsy. Adv Biol Psychiatry 1980; 8: 98105.
  • 80
    Manchanda R, Schaefer B, McLachlan RS, Blume WT. Interictal psychiatric morbidity and focus of epilepsy in treatment refractory patients admitted to an epilepsy unit. Am J Psychiatry 1992; 149: 10968.
  • 81
    Manchanda R, Schaefer B, McLachlan RS, Blume WT. Relationship of site of seizure focus to psychiatric morbidity. J Epilepsy 1995; 8: 238.
  • 82
    Flor-Henry P. Psychosis and temporal lobe epilepsy: a controlled investigation. Epilepsia 1969; 10: 36395.
  • 83
    Deleted in proof.
  • 84
    Rodin E, Schmaltz S. The Bear-Fedio personality inventory and temporal lobe epilepsy. Neurology 1984; 34: 5916.
  • 85
    Naugle RI, Rodgers DA, Stagno SJ, Lalli J. Unilateral temporal lobe epilepsy: an examination of psychopathology and psychosocial behaviour. J Epilepsy 1991; 4: 15764.
  • 86
    Sackheim H, Greenberg MS, Weiman AL, Gur RC Hungersbuhler JP, Geschwind N. Hemispheric asymmetry in the expression of positive and negative emotion. Arch Neurol 1982; 39: 21018.
  • 87
    Dominian J, Serafetinides GA, Dewhurst M. A follow-up study of late-onset epilepsy: II Psychiatric and social findings. BMJ 1963; 1: 4315.
  • 88
    Nielsen H, Kristensen O. Personality correlates of sphenoidal EEG-foci in temporal lobe epilepsy. Acta Neurol Scand 1981; 64: 289300.
  • 89
    Perini G, Mendius R. Depression and anxiety in complex partial seizures. J Nerv Ment Dis 1984; 172: 28790.
  • 90
    Mendez MF, Taylor JL, Doss RC, Salguero P. Depression in secondary epilepsy: relation to lesion laterality. J Neurol Neurosurg Psychiatry 1994; 57: 2323.
  • 91
    Seidenberg M, Hermann B, Noe A, Wyler AR. Depression in temporal lobe epilepsy. Interaction between laterality of lesion and Wisconsin Card Sort performance. Neuropsychiatry Neuropsychol Behav Neurol 1995; 8: 8187.
  • 92
    Robertson M. Mood disorders associated with epilepsy. In: Mc-ConnellHW, SnyderPJ, eds. Psychiatric comorbidity in epilepsy. Basic mechanisms, diagnosis, and treatment. Washington , DC : American Psychiatric Press, 1998: 13267.
  • 93
    Flor-Henry P. On certain aspects of the localisation of the cerebral systems regulating and determining emotion. Biol Psychiatry 1979; 14: 67798.
  • 94
    Deleted in proof.
  • 95
    Engel J Jr, Kuhl DE, Phelps ME, Mazziotta JC. Interictal cerebral glucose metabolism in partial epilepsy and its relation to electro-encephalographic changes. Ann Neurol 1982; 12: 5107.
  • 96
    Baxter LR, Schwartz JM, Phelps ME, et al. Reduction of prefrontal glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989; 46: 24350.
  • 97
    Gallhofer B, Trimble MR, Frackiowiak R, Gibbs J, Jones T. A study of cerebral blood flow and metabolism in epileptic psychosis using positron emission tomography and oxygen. J Neurol Neurosurg Psychiatry 1985; 48: 2016.
  • 98
    Henry TR, Mazziotta JC, Engel JE Jr. Interictal metabolic anatomy of mesial temporal lobe epilepsy. Arch Neurol 1993; 50: 5829.
  • 99
    Schmitz EB, Moriarty J, Costa DC, Ring HA, Eii PJ, Trimble MR. Psychiatric profiles and patterns of cerebral blood flow in focal epilepsy: interactions between depression, obsessionality, and perfusion related to the laterality of the epilepsy. J Neurol Neurosurg Psychiatry 1997; 62: 45863.
  • 100
    Wyler AR, Richey ET, Hermann BP. Comparison of scalp to subdural recordings for localising epileptogenic foci. J Epilepsy 1989; 2: 916.
  • 101
    Bear D, Fedio P. Quantitative analysis of interictal behaviour in temporal lobe epilepsy. Arch Neurol 1977; 34: 45467.
  • 102
    Betts TA. A follow-up study of a cohort of patients with epilepsy admitted to psychiatric care in an English city. In: Harris, P, MawdsleyC, eds. Epilepsy—proceedings of the Hans Berger Centenary Symposium. Churchill Livingston, Edinburgh . 1974: 32638.
  • 103
    Roth DL, Goode KT, Williams VL, Faught E. Physical exercise, stressful life experience, and depression in adults with epilepsy. Epilepsia 1994; 35: 124855.
  • 104
    Baker GA, Nashef L, van Hout BA. Current issues in the management of epilepsy: the impact of frequent seizures on cost of illness, quality of life and mortality. Epilepsia 1995; 38 (suppl 1): S18.
  • 105
    Shorvon S, Reynolds EH. Reduction in polypharmacy for epilepsy. BMJ 1979; 2: 10235.
  • 106
    Smith DB, Collins JB. Behavioral effects of carbamazepine, phe-nobarbital, phenytoin and primidone [Abstract]. Epilepsia 1987; 28: 598.
  • 107
    Brent DA, Crumrine PK, Varma RR, et al. Phenobarbital treatment and major depressive disorder in children with epilepsy. Paediatrics 1987; 80: 90917.
  • 108
    Dodrill CB. Behavioral effects of antiepileptic drugs. In: SmithD, TreimanD, TrimbleM, eds. Advances in Neurology. Vol. 55. New York : Raven Press, 1991: 21324.
  • 109
    Smith DB. Cognitive effects of AEDs. In: SmithDB, TreimanDM, eds. Neurobehavioral problems in epilepsy. Advances in neurology. Vol. 55. New York : Raven Press, 1991: 197212.
  • 110
    Dalby MA. Behavioural effects of carbamazepine. In: PenryJK, DalyDD, eds. Advances in neurology II. New York : Raven Press, 1975: 33144.
  • 111
    Andrewes DG, Bullen JG, Tomlinson L, et al. A comparative study of the cognitive effects of phenytoin and carbamazepine in new referrals with epilepsy. Epilepsia 1986; 27: 12834.
  • 112
    Emrich HM, Dose M, von Zerssen D. The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders. J Affect Disord 1985; 8: 24350.
  • 113
    Post RM, Uhde TW, Joffe RT, Roy-Byrne PP, Kellner C. Anti-convulsant drugs in psychiatric illness: new treatment alternatives and theoretical implications. In: TrimbleMR, ed. The psychopharmacology of epilepsy. Chichester : Wiley, 1985: 14171.
  • 114
    Fenwick PBC. Antiepileptic drugs and their psychotropic effects. Epilepsia 1992; 33 (suppl 6): S336.
  • 115
    McElroy SL, Keck PE, Pope HG. Sodium valproate: its use in primary psychiatric disorders. J Clin Psychopharmacol 1987; 7: 1624.
  • 116
    Balfour JA, Bryson HM. Valproic acid. A review of its pharmacology and therapeutic potential in indications other than epilepsy. CNS Drugs 1994; 2: 14473.
  • 117
    Sander JWAS, Duncan JS. Vigabatrin. In: ShorvonS, DreifussF, FishD, ThomasD, eds. The treatment of epilepsy. Oxford : Black-well Science, 1996: 4919.
  • 118
    Ring HA, Crellin R, Kirker S, Reynolds EH. Vigabatrin and depression. J Neurol Neurosurg Psychiatry 1993; 56: 9258.
  • 119
    Reunanen M, Dam M, Yuen A. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Epilepsy Res 1996; 23: 14955.
  • 120
    Betts T. Lamotrigine in the context of non-pharmacological therapies for epilepsy. Rev Contemp Pharmacother 1994; 5: 1416.
  • 121
    Bisgaard C, Dalby M, Mai J. Lamictal as add-on antiepileptic drug in 210 patients with resistant epilepsy [Abstract]. Epilepsia 1994; 35 (suppl 7): S98.
  • 122
    Wohlfarth R, Saar J, Reinshagen G. Behavioural effects of lamotrigine [Abstract]. Epilepsia 1994; 35 (suppl 7): S72.
  • 123
    Gustev EI, Burd GS. Lamictal in treatment of patients with drugresistant epilepsy. Epilepsia 1994; 36 (suppl 3): S1656.
  • 124
    Mouzichouck L, Maryek G, Obukhova H. Lamotrigine in patients with treatment-resistant epilepsy [Abstract]. Epilepsia 1995; 36 (suppl 3): S114.
  • 125
    Smith D, Baker G, Davies G, Dewey M, Chadwick DW. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993; 34: 31222.
  • 126
    Gillham R, Baker G, Thompson P, et al. Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments. Epilepsy Res 1996; 24: 4755.
  • 127
    Gillham RA, Kane K, Bryant-Comstock L. Relationship between side effect and life satisfaction (SEALS) score, seizure occurrence and side effects to treatment in newly diagnosed patients with epilepsy [Abstract]. Epilepsia 1997; 38 (suppl 3): S163.
  • 128
    Steiner T. Comparison of lamotrigine and phenytoin monotherapy in newly diagnosed epilepsy [Abstract]. Epilepsia 1994; 35 (suppl 8): S31.
  • 129
    Walden J, Hesslinger B, Van-Calker D, Berger M. Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder. Pharmacopsychiatry 1996; 29: 1935.
  • 130
    Calabrese JR, Fatemi SH, Woyshville MJ. Antidepressant effects of lamotrigine in rapid cycling bipolar disorder [Letter]. Am J Psychiatry 1996; 153: 1236.
  • 131
    Sporn J, Sachs G. The anticonvulsant lamotrigine in treatmentresistant manic-depressive illness. J Clin Psychopharmacol 1997; 17: 1859.
  • 132
    Shorvon S, Stefan H. Overview of the safety of newer antiepileptic drugs. Epilepsia 1997; 38 (suppl 1): S4551.
  • 133
    Marson AG, Kadir ZA, Chadwick DW. New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ 1996; 313: 116974.
  • 134
    Ryback RS, Brodsky L, Munasilfi F. Gabapentin in bipolar disorder. J Neuropsychiatry Clin Neurosci 1997; 9: 301.
  • 135
    Schaffer CB, Schaffer LC. Gabapentin in the treatment of bipolar disorder. Am J Psychiatry 1997; 154: 2912.
  • 136
    Nurnberger JI Jr, Berrettini WH, Simmons-Alling S, Guroff JJ, Gershon ES. Intravenous GABA administration is anxiolytic in man. Psychiatry Res 1986; 19: 1137.
  • 137
    Leppik IE. Tiagabine: the safety landscape. Epilepsia 1995; 6 (suppl 6): S103.
  • 138
    Stephen LJ, Brodie MJ. New drug treatments for epilepsy. Prescribers J 1998; 38: 98106.
  • 139
    Leach JP, Brodie MJ. Drug profile: tiagabine. Lancet 1998; 351: 2037.
  • 140
    Dodrill CB, Arnett JL, Shu V, Pixton GC, Lenz GT, Sommerville KW. Effects of tiagabine monotherapy on abilities, adjustment, and mood. Epilepsia 1998; 39: 3342.
  • 141
    Kendrick AM, Duncan JS, Trimble MR. Effects of discontinuation of individual antiepileptic drugs on mood. Hum Psychopharmacol 1993; 8: 26370.
  • 142
    Ketter TA, Malow BA, Flamini R, White SR, Post RM, Theodore WH. Anticonvulsant withdrawal emergent psychopathology. Neurology 1994; 44: 5561.
  • 143
    Pratt JA, Jenner P, Johnson AL, Johnson AL, Shorvon SD, Reynolds EH. Anticonvulsant drugs alter plasma tryptophan concentrations in epileptic patients: implications for antiepileptic action and mental function. J Neurol Neurosurg Psychiatry 1984; 47: 11313.
  • 144
    Edeh J, Toone BK. Antiepileptic therapy, folate deficiency and psychiatric morbidity: a general practice survey. Epilepsia 1985; 26: 43440.
  • 145
    Fröscher W, Maier V, Laage M, et al. Folate deficiency, anticonvulsant drugs, and psychiatric morbidity. Clin Neuropharmacol 1995; 18: 16582.
  • 146
    Klipstein FA. Subnormal serum folate and macrocytosis associated with anticonvulsant drug therapy. Blood 1964; 23: 6886.
  • 147
    Reynolds EH, Chanarin I, Milner G, Matthews DM. Anticonvulsant therapy, folic acid and vitamin B12 metabolism, and mental symptoms. Epilepsia 1966; 7: 26170.
  • 148
    Goggin T, Gough H, Bissessar A, Crowley M, Baker M, Callaghan C. A comparative study of the relative effects of anticonvulsant drugs and dietary folate on the red cell folate status of patients with epilepsy. Q J Med 1987; 65: 9119.
  • 149
    Sander JW, Patsalos PN. An assessment of serum and red blood cell folate concentrations in patients with epilepsy on lamotrigine therapy. Epilepsy Res 1992; 13: 8992.
  • 150
    Carney MWP. Serum folate values in 423 psychiatric patients. BMJ 1967; 4: 5126.
  • 151
    Carney MWP, Chary TKN, Laundy M, et al. Red cell folate concentrations in psychiatric patients. J Affect Disord 1990; 19: 20713.
  • 152
    Godfrey PSA, Toone BK, Carney MWP, et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 1990; 336: 3925.
  • 153
    Reynolds EH. Effects of folic acid on the mental state and fitfrequency of drug-treated epileptic patients. Lancet 1967; 1: 10868.
  • 154
    Crellin R, Bottiglieri T, Reynolds EH. Folates and psychiatric disorders. Clinical potential. Drugs 1993; 45: 62336.
  • 155
    Chanarin I, Laidlaw J, Loughridge LW, Mollin DL. Megaloblastic anaemia due to phenobarbitone. The convulsant action of therapeutic doses of folic acid. BMJ 1960; 1: 1099.
  • 156
    Rausch R, Crandall PH. Psychological status related to surgical control of temporal lobe seizures. Epilepsia 1982; 23: 191202.
  • 157
    Hermann BP, Wyler AR, Ackerman B, Rosenthal T. Short-term psychological outcome of anterior temporal lobectomy. J Neureosurg 1989; 71: 32734.
  • 158
    Hermann BP, Wyler AR, Somes G. Preoperative psychological adjustment and surgical outcome are determinants of psychosocial status after anterior temporal lobectomy. J Neurol Neurosurg Psychiatry 1992; 55: 4916.
  • 159
    Stevens JR. Psychiatric consequences of temporal lobectomy for intractable seizures: a 20–30 year follow-up of 14 cases. Psychol Med 1990; 20: 52945.
  • 160
    Seidman-Ripley JG, Bound VK, Andermann F, Olivier A, Gloor P, Feindel WH. Psychosocial consequences of postoperative seizure relief. Epilepsia 1993; 34: 24854.
  • 161
    Kellett MW, Smith DF, Baker GA, Chadwick DW. Quality of life after epilepsy surgery. J Neurol Neurosurg Psychiatry 1997; 63: 528.
  • 162
    Hill D, Pond DA, Mitchell W, Falconer MA. Personality changes following temporal lobectomy for epilepsy. J Ment Sci 1957; 103: 1827.
  • 163
    Bladin PF. Psychosocial difficulties and outcome after temporal lobectomy. Epilepsia 1992; 33: 898907.
  • 164
    Vickrey BG, Hays RD, Graber J, Rausch R, Engel J Jr, Brook RH. A health-related quality of life instrument for patients evaluated for epilepsy surgery. Med Care 1992; 30: 299319.
  • 165
    Fenwick P. Longterm psychiatric outcome after epilepsy surgery. In: LüdersH, ed. Epilepsy surgery. New York : Raven Press, 1991: 64752.
  • 166
    Naylor AS, Rogvi-Hansen B, Kessing L, Kruse-Larsen C. Psychiatric morbidity after surgery for epilepsy: short-term follow up of patients undergoing amygdalohippocampectomy. J Neurol Neurosurg Psychiatry 1994; 57: 137581.
  • 167
    Falconer MA, Serafetinides EA. A follow-up study of surgery in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 1963; 26: 15463.
  • 168
    Bruton CJ. The neuropathology of temporal lobe epilepsy. Maudsley monographs. Oxford : Oxford University Press, 1988.
  • 169
    Krahn LE, Rummans TA, Peterson GC, Cascino GD, Sharbrough FW. Electroconvulsive therapy for depression after temporal lobectomy for epilepsy. Case report. Convulsive Ther 1993; 9: 2179.
  • 170
    Parashos IA, Oxley SL, Boyko OB, Krishnan KRR. In vivo quantitation of basal ganglia and thalamic degenerative changes in two temporal lobectomy patients with affective disorder. J Neuropsychiatry Clin Neurosci 1993; 5: 33741.
  • 171
    Chovaz CJ, McLachlan RS, Derry PA, Cummings AL. Psychosocial function following temporal lobectomy: influence of seizure control and learned helplessness. Seizure 1994; 3: 1716.
  • 172
    Krahn LE, Rummans TA, Peterson GC. Psychiatric implications of surgical treatment of epilepsy. Mayo Clin Proc 1996; 71: 12014.
  • 173
    Ferguson SM, Rayport M. The adjustment to living without epilepsy. J Nery Ment Dis 1965; 140: 2637.
  • 174
    Usiskin S. Counseling in epilepsy. In: HopkinsA, ShorvonS, CascinoG, eds. Epilepsy. 2nd ed. London : Chapman & Hall, 1995: 56571.
  • 175
    Thompson PJ. The rehabilitation of people with epilepsy. In: HopkinsA, ShorvonS, CascinoG, eds. Epilepsy. 2nd ed. London : Chapman & Hall, 1995: 5739.
  • 176
    Rausch R. Effects of temporal lobe surgery on behavior. In: SmithDB, TreimanDM, eds. Neurobehavioral problems in epilepsy. Advances in neurology. Vol. 55. New York : Raven Press, 1991: 27992.
  • 177
    Abramson LY, Seligman MEP, Teasdale JD. Learned helplessness in humans: critique and reformulation. J Abnorm Psychol 1978; 87: 4974.
  • 178
    Hermann BP. Psychopathology in epilepsy and learned helplessness. Med Hypotheses 1979; 5: 7239.
  • 179
    De Vellis RF, De Vellis BM, Wallston BS, Wallston KA. Epilepsy and learned helplessness. Basic Appl Social Psychol 1980; 1: 24153.
  • 180
    Hermann BP, Trenerry MR, Colligan RC. Learned helplessness, attributional style and depression in epilepsy. Epilepsia 1996; 37: 6806.
  • 181
    Hermann BP. Quality of life in epilepsy. J Epilepsy 1992; 5: 15365.
  • 182
    Baker GA, Smith DF, Dewey M, Jacoby A, Chadwick DW. The initial development of a health-related quality of life model as an outcome measure in epilepsy. Epilepsy Res 1993; 16: 6581.
  • 183
    Perrine K, Hermann BP, Meador KJ, et al. The relationship of neuropsychological functioning to quality of life in epilepsy. Arch Neurol 1995; 52: 9971003.
  • 184
    Rodin EA, Shapiro HL, Lennox K. Epilepsy and life performance. Rehab Lit 1977; 38: 349.
  • 185
    Dodrill CB, Breyer DN, Diamond MB, Dubinsky BL, Geary BB. Psychosocial problems among adults with epilepsy. Epilepsia 1984; 25: 16875.
  • 186
    Greist JH, Klein MH, Eischens RR, Faris J, Gurman AL, Morgan WP. Running for treatment of depression. Comprehens Psychiatry 1979; 20: 4154.
  • 187
    McCann IL, Holmes DS. Influence of aerobic exercise on depression. J Personal Soc Psychol 1984; 46: 11427.
  • 188
    Roth DL. Acute emotional and psychophysiological effects of aerobic exercise. Psychophysiology 1990; 26: 593602.
  • 189
    Nakken KO, Bjorholt PG, Johannessen SI, Lφyning T, Lind E. Effects of physical training on aerobic capacity, seizure occurrence, and serum level of antiepileptic drugs in adults with epilepsy. Epilepsia 1990; 31: 8894.
  • 190
    Rutter M, Graham P, Yule W. A neuropsychiatric study in childhood. London : Heinemann, 1970.
  • 191
    Schneider JW, Conrad P. In the closet with illness: epilepsy, stigma potential and information control. Social Probl 1980; 28: 3244.
  • 192
    Long CG, Moore JR. Parental expectations for their epileptic children. J Child Psychol Psychiatry 1979; 20: 299312.
  • 193
    Hauck C. Sociological aspects of epilepsy research. Epilepsia 1972; 13: 7985.
  • 194
    Goffman E. Stigma: notes on the management of spoiled identity. Englewood Cliffs , NJ : Prentice-Hall, 1963.
  • 195
    Jacoby A. Felt versus enacted stigma: a concept revisited. Evidence from a study of people with epilepsy in remission. Social Sci Med 1994; 38: 26974.
  • 196
    Lennox GW, Lennox MA. Epilepsy and related disorders. Vol. 1. Boston : Little, Brown, 1960.
  • 197
    Mark VH, Ervin FR. Violence and the brain. New York : Harper and Row, 1970.
  • 198
    Devinsky O, Bear D. Varieties of aggressive behaviour in temporal lobe epilepsy. Am J Epilepsy 1984; 141: 6516.
  • 199
    Treiman D. Psychobiology of ictal aggression. In: SmithDB, TreimanDM, eds. Neurobehavioral problems in epilepsy. Advances in Neurology. Vol. 55. New York : Raven Press, 1991: 34156.
  • 200
    Arangio AJ. Behind the stigma of epilepsy. Washington , DC : Epilepsy Foundation of America, 1975.
  • 201
    Thompson P, Oxley J. Social aspects of epilepsy. In: LaidlawJ, RichensA, ChadwickD, eds. A textbook of epilepsy. 4th ed. Edinburgh : Churchill-Livingstone, 1993: 661704.
  • 202
    Scambler G, Hopkins A. Generating a model of epileptic stigma. The role of qualitative analysis. Social Sci Med 1990; 30: 118794.
  • 203
    Ryan R, Kemper K, Emlen AC. The stigma of epilepsy as a self-concept. Epilepsia 1980; 21: 43344.
  • 204
    Arnston P. The perceived psychosocial consequences of having epilepsy. In: WhitmanS, HermannB, eds. Psychopathology in epilepsy: social dimensions. Oxford : Oxford University Press, 1986: 14361. New York.
  • 205
    Scambler G, Hopkins A. Being epileptic: coming to terms with stigma. Soc Health Illness 1986; 8: 2643.
  • 206
    Mittan R. Fear of seizures. In: WhitmanS, HermannBP, eds. Psychopathology in epilepsy: social dimensions. New York : Oxford University Press, 1986: 90121.
  • 207
    Mittan R. The influence of seizure-related variables upon patients' fears of death and brain damage [Abstract]. Epilepsia 1987; 28: 540.
  • 208
    Goldstein J, Seidenberg M, Peterson R. Fear of seizures and behavioral functioning in adults with epilepsy. J Epilepsy 1990; 3: 1016.
  • 209
    Mayou R, Hawton K. Psychiatric disorder in the general hospital. Br J Psychiatry 1986; 149: 17290.
  • 210
    Roberts A. The use of antidepressant drugs in general practice. Prescriber 1995; 5: 3553.
  • 211
    Cunningham LA. Depression in the medically ill: choosing an antidepressant. J Clin Psychiatry 1994; 55 (9, suppl A): 907.
  • 212
    Betts TA. Depression, anxiety and epilepsy. In: ReynoldsEH, TrimbleMR, eds. Epilepsy and Psychiatry. Edinburgh : Churchill Livingstone, 1981: 6071.
  • 213
    World Health Organisation. The 1CD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva : WHO, 1992.
  • 214
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington , DC : American Psychiatric Association, 1994.
  • 215
    Spitzer RL, Endicott J, Robins E. Research diagnostic criteria. Arch Gen Psychiatry 1978; 35: 77382.
  • 216
    Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 5662.
  • 217
    Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 56171.
  • 218
    Pilowsky I, Levine S, Boulton DM. The classification of depression by numerical taxonomy. Br J Psychiatry 1969; 115: 93745.
  • 219
    Carney MWP, Roth M, Garside RF. The diagnosis of depressive syndromes and the prediction of ECT response. Br J Psychiatry 1965; 111: 65974.
  • 220
    Blumer D. Epilepsy and disorders of mood. In: SmithDB, TreimanDM, TrimbleMR, eds. Neurobehavioral problems in epilepsy. New York : Raven Press, 1991: 18595.
  • 221
    Blumer D, Montouris G, Hermann B. Psychiatric morbidity in seizure patients on a neurodiagnostic monitoring unit. The Journal of Neuropsychiatry and Clinical Neurosciences 1995; 7: 445456.
  • 222
    Ziegler RG. Impairments of control and competence in epileptic children and their families. Epilepsia 1981; 22: 33946.
  • 223
    Davis GR, Armstrong HE, Donovan DM, Temkin NR. Cognitive-behavioural treatment of depressed affect amongst epileptics: preliminary findings. J Clin Psychol 1984; 4: 9305.
  • 224
    Gehlert S. Perceptions of control in adults with epilepsy. Epilepsia 1994; 35: 818.
  • 225
    Becú M, Becú N, Manzur G, Kochen S. Self-help epilepsy groups: an evaluation of effect on depression and schizophrenia. Epilepsia 1993; 34: 8415.
  • 226
    Jacoby A. Epilepsy and the quality of everyday life. Findings from a study of people with well-controlled epilepsy. Social Sci Med 1992; 42: 65766.
  • 227
    Klerman GL. Treatment of recurrent unipolar major depressive disorder: commentary on the Pittsburgh Study. Arch Gen Psychiatry 1990; 47: 115861.
  • 228
    Kupfer DJ, Frank E, Perel JM. The advantage of early treatment intervention in recurrent depression. Arch Gen Psychiatry 1989; 46: 7715.
  • 229
    Tyrer P. Drug treatment of psychiatric patients in general practice. BMJ 1978; 2: 100810.
  • 230
    Keller MB, Lavori PW, Klerman GL, et al. Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients. Arch Gen Psychiatry 1986; 43: 45868.
  • 231
    Prien RF, Kupfer DJ. Continuation drug therapy for major depressive episodes: how long should it be maintained Am J Psychiatry 1986; 143: 1823.
  • 232
    Blackwell B. MAOI interactions with other drugs. J Clin Neuropharmacol 1991; 11: 559.
  • 233
    Versiani M, Nardi AE, Figueira ILV, Stabl M. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo. Acta Psychiatr Scand 1990; 82 (suppl 360):248.
  • 234
    Davis JM, Glassman AH. Antidepressant drugs. In KaplanHI, SadockBJ, eds. Comprehensive Textbook of Psychiatry V. 5th edition. Baltimore : Williams & Wilkins, 1989;162755.
  • 235
    Series HG. Drug treatment of depression in medically ill patients. J Psychosom Res 1992; 36: 116.
  • 236
    Kasper S, Fuger J, Möller HJ. Comparative efficacy of antidepressants. Drugs 1992; 43: 1122.
  • 237
    Swinkels JA, de Jonghe F. Safety of antidepressants. Int Clin Psychopharmacol 1995;9(suppl 4):1925.
  • 238
    Montgomery SA. Rapid onset of action of venlafaxine. Int Clin Psychopharmacol 1995a;10(suppl 2):217.
  • 239
    Robertson MM, Trimble MR. The treatment of depression in patients with epilepsy. J Affect Disord 1985; 9: 12736.
  • 240
    ABPI. Compendium of data sheets and summaries of product characteristics. London : Datapharm Publications, 1996.
  • 241
    Ketter TA, Post RM, Parekh PI, Worthington K. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression. J Clin Psychiatry 1995; 56: 4715.
  • 242
    Amrein R, Güntert TW, Dingemanse J, Lorschied T, Stabl M, Schmid-Burgk W. Interactions of moclobemide with concomitantly administered medication: evidence from pharmacological and clinical studies. Psychopharmacology 1992;106:S2431.
  • 243
    Dursun SM, Matthew VM, Reveley MA. Toxic serotonin syndrome after fluoxetine plus carbamazepine. Lancet 1993; 342: 4423.
  • 244
    Nemeroff CB, De Vane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996; 153: 31120.
  • 245
    Brφsen K. Recent developments in hepatic drug oxidation: implications for clinical pharmacokinetics. Clin Pharmacokinet 1990; 18: 22039.
  • 246
    Levy RH. Cytochrome P450 isoenzymes and antiepileptic drug interactions. Epilepsia 1995; 36 (suppl 5): S813.
  • 247
    Jalil P. Toxic reaction following the combined administration of fluoxetine and phenytoin: two case reports. J Neurol Neurosurg Psychiatry 1992; 55: 4123.
  • 248
    Darley J. Interaction between phenytoin and fluoxetine. Seizure 1994; 3: 1512.
  • 249
    Woods DJ, Coulter DM, Pillans P. Interaction of phenytoin and fluoxetine [Letter]. N Zeal Med J 1994; 107: 19.
  • 250
    Shader RI, Greenblatt DJ, von Moltke LL. Fluoxetine inhibition of phenytoin metabolism. J Clin Psychopharmacol 1994; 45: 3756.
  • 251
    Haselberger MB, Freedman LS, Tolbert S. Elevated serum phenytoin concentrations associated with coadministration of sertraline. J Clin Psychopharmacol 1997; 17: 1079.
  • 252
    Rapeport WG, Williams SA, Muirhead DC, Dewland PM, Tanner T, Wesnes K. Absence of a sertraline-mediated effect on the pharmacokinetics and pharmacodynamics of carbamazepine. J Clin Psychiatry 1996; 57 (suppl 1): S203.
  • 253
    Andersen BB, Mikkelsen M, Vesterager A, et al. No influence of the antidepressant paroxetine on carbamazepine, valproate and phenytoin. Epilepsy Res 1991; 10: 2014.
  • 254
    Grimsley SR, Jann MW, Carter JG, D'Mello AP, D'Souza MJ. Increased carbamazepine plasma concentrations after fluoxetine coadministration. Clin Pharmacol Ther 1991; 50: 105.
  • 255
    Pearson HJ. Interaction of fluoxetine with carbamazepine [Letter]. J Clin Psychiatry 1990; 51: 126.
  • 256
    Gernaat HBPE, van de Woude J, Touw DJ. Fluoxetine and parkinsonism in patients taking carbamazepine. Am J Psychiatry 1991; 148: 16045.
  • 257
    Fritze J, Unsorg B, Lanczik M. Interaction between carbamazepine and fluvoxamine. Acta Psychiatr Scand 1991; 84: 5834.
  • 258
    Martinelli V, Bocchetta A, Palmas AM, Del Zompo M. An interaction between carbamazepine and fluvoxamine. Br J Clin Pharmacol 1993; 36: 6156.
  • 259
    Joblin M. Possible interaction of sertraline with carbamazepine [Letter]. N Zeal Med J 1994; 107: 43.
  • 260
    Ashton AK, Wolin RE. Nefazodone-induced carbamazepine toxicity. Am J Psychiatry 1996; 153: 733.
  • 261
    Pisani F, Fazio A, Oteri G, et al. Carbamazepine-viloxazine interaction on patients with epilepsy. J Neurol Neurosurg Psychiatry 1986; 49: 11425.
  • 262
    Deleted in proof.
  • 263
    Spina E, Ayenoso A, Pollicino AM, et al. No effect of fluvoxamine or fluoxetine on plasma concentrations of carbamazepine in epileptic patients. Pharmacol Res 1992; 25(suppl 2):2145.
  • 264
    Kasper S, Praschak-Rieder N, Tauscher J, Wolf R. A risk-benefit assessment of mirtazapine in the treatment of depression. Drug Safety 1997; 17: 25164.
  • 265
    Dahl ML, Voortman G, Alm C, et al. In vitro and in vivo studies on the disposition of mirtazapine in man. Clin Drug Invest 1997; 13: 3746.
  • 266
    Gailer JL, Edwards SM. SSRIs and anticonvulsants. Aust J Hosp Pharmacol 1996; 26: 5878.
  • 267
    Jeppesen U, Gram LF, Vistisen K, Loft S, Poulson HE, Brφsen K. Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine. Eur J Clin Pharmacol 1996; 51: 738.
  • 268
    Brodie MJ. Drug interactions in epilepsy. Epilepsia 1992; 33 (suppl 1): S1322.
  • 269
    Spina E, Pisani F, Perucca E. Clinically significant pharmacoki-netic drug interactions with carbamazepine. An update. Clin Pharmacokinet 1996; 31: 198214.
  • 270
    Boyer WF, Blumhardt CL. The safety profile of paroxetine. Journal of Clinical Psychiatry 1992;53(suppl 2):6166.
  • 271
    Blacker R, Shanks NJ, Chapman N, Davey A. The drug treatment of depression in general practice: a comparison of nocte administration of trazodone with mianserin, dothiepin and amitriptyline. Psychopharmacology 1988; 95:S1824.
  • 272
    Hindmarch I, Alford C, Barwell F, Kerr JS. Measuring the side effects of psychotropics: the behavioural toxicity of antidepressants. J Psychopharmacol 1992; 6: 198203.
  • 273
    Itil TM, Soldatos C. Epileptogenic side effects of psychotropic drugs. JAMA 1980; 244: 14603.
  • 274
    Monti JM. Effect of a reversible monoamine oxidase A inhibitor (moclobemide) on sleep of depressed patients. Br J Psychiatry 1989;155(suppl 6):615.
  • 275
    Armitage R, Rush AJ, Trivedi M, Cain J, Roffware HP. The effects of nefazodone on sleep architecture in depression. Neuro-psychopharmacology 1994; 10: 1237.
  • 276
    Ruigt GSF, Kemp B, Groenhout CM, Kamphuisen HAC. Effect of the antidepressant ORG 3770 on human sleep. Eur J Clin Psychopharmacol 1990; 38: 5514.
  • 277
    Ramaekers JG, Muntjewerff ND, O'Hanlon JF. Acute and subchronic effects of mirtazapine (15/30 mg nocte) and mianserin (30/60 mg nocte) on psychomotor and actual driving performance and sleep in healthy, young volunteers. Eur Neuropsychopharmacol 1995; 6: 2945.
  • 278
    Mattila M, Mattila MJ, Vrijmoed-de Vries M, Kuitunen T. Actions and interactions of psychotropic drugs on human performance and mood: single doses of ORG 3770, amitriptyline and mood. Pharmacol Toxicol 1989; 65: 818.
  • 279
    Patris M, Bouchard J-M, Bougerol T, et al. Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice. Int Clin Psychopharmacol 1996; 11: 12936.
  • 280
    Schweizer E, Weise C, Clary C, et al. Placebo-controlled trial of venlafaxine for the treatment of major depression. J Clin Psychopharmacol 1991; 11: 2336.
  • 281
    Thompson PJ. Memory function in patients with epilepsy. In: SmithD, TreimanD, TrimbleM, eds. Neurobehavioral problems in epilepsy. Advances in neurology. Vol. 55. New York : Raven Press, 1991: 36984.
  • 282
    Cole KD, Zarit SH. Psychological deficits in depressed medical patients. J Nerv Ment Disord 1984; 172: 1505.
  • 283
    Thompson PJ. Antidepressants and memory: a review. Hum Psychopharmacol 1991; 6: 7990.
  • 284
    Toone BK, Edeh J, Nanjee MN, Wheeler M. Hyposexuality and epilepsy: a community survey of hormonal and behavioural changes in male epileptics. Psychol Med 1989; 19: 93743.
  • 285
    Jensen P, Jensen SB, Sorensen PS, et al. Sexual dysfunction in male and female patients with epilepsy: a study of 86 outpatients. Arch Sexual Behav 1990; 19: 114.
  • 286
    Ndegwa D, Rust J, Golombok S, Fenwick P. Sexual problems in epileptic women. Sex Marital Ther 1986; 1: 1757.
  • 287
    Morrell MJ, Guldner GT. Self-reported sexual function and sexual arousability in women with epilepsy. Epilepsia 1996; 37: 120410.
  • 288
    Nofzinger EA. Thase Me, Reynold III CF, et al. Sexual function in depressed men: assessment by self report, behavioral and nocturnal penile tumescence measures before and after treatment with cognitive behavior therapy. Arch Gen Psychiatry 1993; 50: 2430.
  • 289
    Margolese HC, Assalian P. Sexual side effects of antidepressants: a review. J Sex Marital Ther 1996; 22: 20917.
  • 290
    Balon R, Yeragani VK, Pohl R, Ramesh C. Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 1993; 54: 20912.
  • 291
    Warner MD, Peabody CA, Whiteford HA, Hollister LE. Trazodone and priapism. J Clin Psychiatry 1987; 48: 2445.
  • 292
    Gitlin MJ. Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches. J Clin Psychiatry 1994; 55: 40613.
  • 293
    Baldwin D, Johnson FN. Tolerability and safety of citalopram. Rev Contemp Pharmacother 1995; 6: 31525.
  • 294
    Montgomery SA. Safety of mirtazapine: a review. Int Clin Psychopharmacol 1995;10(suppl 4):3745.
  • 295
    Klint T, Helsdingen JT. Lack of typical SSRI-related adverse effects and sexual dysfunction with mirtazapine is related to specific blockade of 5-HT2 and 5-HT3 receptors [Abstract]. Eur Psychiatry 1996;11(suppl 4):3475.
  • 296
    Rekers H, Kremer C, Zivkov M. Treatment with mirtazapine is not related to complaints of sexual dysfunction [Abstract]. Eur Neuropsychopharmacol 1996;6(suppl 3):47.
  • 297
    Stimmel GL, Dopheide JA, Stahl SM. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects. Pharmacology 1997; 17: 1021.
  • 298
    Baldwin DS. Depression and sexual function. J Psychopharmacol 1996;10(suppl 1):304.
  • 299
    Phillip M, Kohnen R, Benkert O. A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction. Int J Clin Psychopharmacol 1993; 7: 14953.
  • 300
    Assalian P, Margolese HC. Treatment of antidepressant induced sexual side effects. J Sex Marital Ther 1996; 22: 21824.
  • 301
    Brooke G, Weatherly JRC. Imipramine. Lancet 1959; 2: 5689.
  • 302
    Rosenstein DL, Nelson JC, Jacobs SC. Seizures associated with antidepressants: a review. J Clin Psychiatry 1993; 54: 28999.
  • 303
    Hauser WA, Kurland LT. The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia 1975; 16: 166.
  • 304
    Davidson J. Seizures and bupropion: a review. J Clin Psychiatry 1989; 50: 25661.
  • 305
    Settle EC Jr. Bupropion sustained release: side effect profile. J Clin Psychiatry 1998;59(suppl 4):326.
  • 306
    Wroblewski BA, McColgan K, Smith K, et al. The incidence of seizures during tricyclic antidepressant drug treatment in a brain-injured population. J Clin Psychopharmacol 1990; 10: 1248.
  • 307
    Skowron DM, Stimmel GL. Antidepressants and the risk of seizures. Pharmacotherapy 1992; 12: 1822.
  • 308
    Jick H, Dinan BJ, Hunter JR, et al. Tricyclic antidepressants and convulsions. J Clin Psychopharmacol 1983; 3: 1825.
  • 309
    Förstl H, Pohlmann-Eden B. Monitoring antidepressant-induced cerebral hyperexcitability [Letter]. J Clin Psychiatry 1993; 54: 5.
  • 310
    Peck AW, Stern WC, Watkinson C. Incidence of seizures during treatment with tricyclic antidepressant drugs and bupropion. J Clin Psychiatry 1983;44(5 Pt 2):197201.
  • 311
    Preskorn SH, Fast GA. Tricyclic antidepressant-induced seizures and plasma drug concentration. J Clin Psychiatry 1992; 53: 1602.
  • 312
    Ojemann LM, Friel PN, Trejo WJ, Dudley DL. Effect of doxepin on seizure frequency in depressed epileptic patients. Neurology 1983; 33: 6468.
  • 313
    Magnus RV. A placebo controlled trial of viloxazine with and without tranquilizers in depressive illness. J Int Med Res 1975; 3: 20713.
  • 314
    Meldrum BS, Anlezark GM, Adam HK, Greenwood DT. Anti-convulsant and proconvulsant properties of viloxazine hydrochloride: pharmacological and pharmacokinetic studies in rodents and the epileptic baboon. Psychopharmacology 1982; 76: 212.
  • 315
    Leyrie J. A special indication for viloxazine. Psychol Med 1981; 13: 109.
  • 316
    Fromm GH, Wessel HB. Glass JD, Alvin JD, Van Horn G. Imipramine in absence and myoclonic-astatic seizures. Neurology 1978; 28: 797804.
  • 317
    Tasini M. Complex partial seizures in a patient receiving trazodone. J Clin Psychiatry 1986; 47: 3189.
  • 318
    Wedin GP, Oderda GM, Klein-Schwartz W, et al. Relative toxicity of cyclic antidepressants. Ann Emerg Med 1986; 15: 7.
  • 319
    Baldessarini RJ. Drugs and the treatment of psychiatric disorders: depression and mania. In: HardmanJG, LimbirdLE, MolinoffPB, RuddonRW, and GilmanAG, eds. The pharmacological basis of therapeutics. New York : McGraw-Hill, 1996;43159.
  • 320
    Deahl M, Trimble M. Serotonin reuptake inhibitors, epilepsy and myoclonus. Br J Psychiatry 1991; 159: 4335.
  • 321
    Murthy R, Newton K, Qureshi J. The association of fluoxetine with seizures. J Psychopharmacol 1994; 8: 1878.
  • 322
    Webber JJ. Seizure activity associated with fluoxetine therapy. Clin Pharm 1989; 8: 2968.
  • 323
    Ware MR, Stewart RB. Seizures associated with fluoxetine therapy [Letter]. Ann Pharmacother 1989; 23: 428.
  • 324
    Grady TA, Pigott TA, L'Heureux F, Murphy DL. Seizure associated with fluoxetine and adjuvant buspirone therapy. J Clin Psychopharmacol 1992; 12: 7071.
  • 325
    Wroblewski B, Guidos A, Leary JM, Joseph AB. Control of depression with fluoxetine and anti-seizure medication in a brain injured patient [Letter]. Am J Psychiatry 1992; 149: 273.
  • 326
    Prasher VP. Seizures associated with fluoxetine therapy. Seizure 1993; 2: 3157.
  • 327
    Sternbach H. Fluoxetine-clomiphene interaction. J Clin Psychiatry 1995; 56: 1712.
  • 328
    Hargrave R, Martinez D, Bernstein AJ, Hayward CA. 1992. Fluoxetine-induced seizures. Psychosomatics 1992; 33: 2367.
  • 329
    Gigli GL, Diomedi M, Troisi A, et al. Lack of potentiation of anticonvulsant effect by fluoxetine in drug-resistant epilepsy. Seizure 1994; 3: 2214.
  • 330
    Levine R, Kenin M, Hoffman JS, Day KE. Grand mal seizures associated with the use of fluoxetine [Letter]. J Clin Psychopharmacol 1994; 14: 1456.
  • 331
    Hwang AS, Magraw RM. Syndrome of inappropriate secretion of antidiuretic hormone due to fluoxetine [Letter]. Am J Psychiatry 1989; 146: 399.
  • 332
    Cohen BJ, Mahelsky M, Adler L. More cases of SIADH with fluoxetine [Letter]. Am J Psychiatry 1990; 147: 9489.
  • 333
    Goddard C, Paton C. Hyponatraemia associated with paroxetine [Letter]. BMJ 1992; 305: 1332.
  • 334
    Crews JR, Potts NLS, Schreiber J, Lipper S. Hyponatraemia in a patient treated with sertraline [Letter]. Am J Psychiatry 1993; 150: 1564.
  • 335
    Messiha FS. Fluoxetine: adverse effects and drug-drug interactions. Clin Toxicol 1993; 31: 60330.
  • 336
    Ball CJ, Herzberg J. Hyponatraemia and selective serotonin re-uptake inhibitors. Int J Geriatr Psychiatry 1994; 9: 81922.
  • 337
    Flint AJ, Crosby J, Genik JL. Recurrent hyponatraemia associated with fluoxetine and paroxetine [Letter]. Am J Psychiatry 1996; 153134.
  • 338
    Goldstein L, Barker M, Segall F, et al. Seizure and transient SIADH associated with sertraline [Letter]. Am J Psychiatry 1996; 153: 732.
  • 339
    Voegeli J, Baumann P. Inappropriate secretion of antidiuretic hormone and SSRIs. Br J Psychaitry 1996; 169: 5245.
  • 340
    Bouman WP, Johnson H, Pinner G. Inappropriate antidiuretic hormone secretion and SSRIs. Br J Psychiatry 1997; 170: 8889.
  • 341
    Bouman WP, Pinner G, Johnson H. Incidence of selective serotonin reuptake inhibitor (SSRI) induced hyponatraemia due to the syndrome of inappropriate antidiuretic hormone (SIADH) secretion in the elderly. Int J Geriatr Psychiatry 1998; 13: 125.
  • 342
    Committee on Safety of Medicines. Antidepressant-induced hyponatraemia. Curr Probl Pharmacovigilance 1994; 20: 56.
  • 343
    Liu BA, Mittmann N, Knowles SR, Shear NH. Hyponatraemia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports. J Can Med Assoc 1996; 155: 51927.
  • 344
    Kalff R, Houtkooper MA, Meyer JWA, Goedhart DM, Augusteijn R, Meinardi H. Carbamazepine and serum sodium levels. Epilepsia 1984; 25: 3907.
  • 345
    Leander JD. Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine and ameltolide (LY201116). Epilepsia 1992; 33: 5736.
  • 346
    Favale E, Rubino V, Mainardi P, Lunardi G, Albano C. Anticonvulsant effect of fluvoxamine in humans. Neurology 1995; 45: 19267.
  • 347
    Troisi A, Vicario E, Nuccetelli F, Ciani N, Pasini A. Effects of fluoxetine on aggressive behaviour of adult inpatients with mental retardation and epilepsy. Pharmacopsychiatry 1995; 28: 736.
  • 348
    Wernicke JF. The side effect profile and safety of fluoxetine. J Clin Psychiatry 1985; 46: 5967.
  • 349
    Harmant J, van Rijckevorsel-Harmant K, De Barsy Th, Hendrickx B. Fluvoxamine: an antidepressant with low (or no) epileptogenic effect [Letter]. Lancet 1990; 2: 386.
  • 350
    Sedgewick EM, Cilasun J, Edwards JG. Paroxetine and the electroencephalogram. J Clin Psychopharmacol 1987; 1: 314.
  • 351
    Chandler LP, Rasmussen JGC. Analysis of seizure potential in the sertraline, placebo, and active control groups in the sertraline development program [Abstract]. Clin Neuropharmacol 1992;15(suppl 1B):317B.
  • 352
    Lader M, Melhuish A, Frcka G, Fredricson Overø K, Christensen V. The effects of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy subjects. Eur J Clin Pharmacol 1986; 31: 18390.
  • 353
    Blumer D. Antidepressant and double antidepressant treatment for the affective disorder of epilepsy. J Clin Psychiatry 1997; 58: 311.
  • 354
    Edwards JG, Wheal HV. Assessment of epileptogenic potential: experimental, clinical and epidemiological approaches. J Pharmacol 1992; 6: 20413.
  • 355
    Danjou P, Hackett D. Safety and tolerance profile of venlafaxine. Int Clin Psychopharmacol 1995;10(suppl 2):1520.
  • 356
    Hilton S, Jaber B, Ruch R. Moclobemide safety: monitoring a newly developed product in the 1990s. J Clin Psychopharmacol 1995; 15 (suppl 2): S7683.
  • 357
    Marcus RN. Safety and tolerability profile of nefazodone. J Psychopharmacol 1996;10(suppl 1):117.
  • 358
    Richou H, Ruimy P, Charbaut J, Delise JP, Brunner H, Patris M. A multicenter double-blind, clomipramine-controlled efficacy and safety study of ORG 3770. Hum Psychopharmacol 1995; 10: 26371.
  • 359
    Committee on Safety of Medicines. Guidance on the interpretation of yellow card data. Medicines Control Agency, 1997.
  • 360
    McConnell HW, Duncan D. Treatment of psychiatric comorbidity in epilepsy. In: McConnellHW, SnyderPJ, eds. Psychiatric comorbidity in epilepsy. Basic mechanisms, diagnosis, and treatment. Washington , DC : American Psychiatric Press, 1998;245362.
  • 361
    Dailey JW, Naritoku DK. Antidepressants and seizures: clinical anecdotes overshadow neuroscience. Biochem Pharmacol 1996; 52: 13239.
  • 362
    Frommer DA, Kulig KW, Marx JA, Rumack B. Tricyclic anti-depressant overdose: a review. JAMA 1987; 257: 5216.
  • 363
    Hulten BA, Heath A. Clinical aspects of tricyclic antidepressant poisoning. Acta Med Scand 1983; 213: 2758.
  • 364
    Buckley NA, Dawson AH, Whyte IM, Henry DA. Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants. Lancet 1994;343:15962.
  • 365
    Knudsen K, Heath A. Effects of self poisoning with maprotiline. BMJ 1984; 288: 6013.
  • 366
    Wyss PA, Serena S, Meier PJ. Dose-dependency of seizures in maprotiline (Ludiomil) intoxications [Abstract]. Veterin Hum Toxicol 1993; 35: 341.
  • 367
    Litovitz TL, Troutman WG. Amoxapine overdose. JAMA 1983; 250: 106971.
  • 368
    Personne M, Persson H, Sjöberg G. Citalopram toxicity. Lancet 1997; 350: 5189.
  • 369
    Cassidy S. Henry J. Fatal toxicity of antidepressant drugs in overdose. BMJ 1987; 295: 10214.
  • 370
    Deleted in proof.
  • 371
    Ostrom M, Eriksson A, Thorson J, Spigset O. Fatal overdose with citalopram. Lancet 1996; 348: 33940.
  • 372
    Brion F, Brion N, Durigon M. Fatal overdose with citalopram Lancet 1996; 348: 1380.
  • 373
    Glassman AH. Citalopram toxicity. Lancet 1997; 350: 818.
  • 374
    Shukla S, Mukherjee S, Decina P. Lithium in the treatment of bipolar disorders associated with epilepsy: an open study. J Clin Psychopharmacol 1988; 8: 2014.
  • 375
    Lyketsos CG, Stoline AM, Longstreet P, et al. Mania in temporal lobe epilepsy. Neuropsychiatry Neuropsychol Behav Neurol 1993; 6: 1925.
  • 376
    Schou M, Amdisen A, Trap-Jensen J. Lithium poisoning. Am J Psychiatry 1968; 125: 5207.
  • 377
    Wharton RN. Grand mal seizures with lithium treatment. Am J Psychiatry 1969; 125: 152.
  • 378
    Spring GK. EEG observations in confirming neurotoxicity [Letter]. Am J Psychiatry 1979; 136: 1099100.
  • 379
    Simard M, Gumbiner B, Lee A, et al. Lithium carbonate intoxication. A case report and review of the literature. Arch Intern Med 1989; 194: 3646.
  • 380
    Demers R, Lukesh R, Prichard J. Convulsion during lithium therapy [Letter]. Lancet 2:3156.
  • 381
    Baldessarini RJ, Stephens JH. Lithium carbonate for affective disorders. Arch Gen Psychiatry 1970; 22: 727.
  • 382
    Jus A, Villeneuve A, Gauthier J, et al. Influence of lithium carbonate on patients with temporal lobe epilepsy. Can J Psychiatry 1973; 18: 778.
  • 383
    Moore DP. A case of petit mal epilepsy aggravated by lithium. Am J Psychiatry 1981; 138: 6901.
  • 384
    Massey EW, Folger WN. Seizures activated by therapeutic levels of lithium carbonate. South Med J 1984; 77: 11735.
  • 385
    Julius SC, Brenner RP. Myoclonic seizures with lithium. Biol Psychiatry 1987; 22: 118490.
  • 386
    Rosen RB, Stevens R. Action myoclonus in lithium toxicity. Ann Neurol 1983; 13: 2212.
  • 387
    Thau K, Rappelsberger P, Lovrek A, Petsche H, Simhandl Ch, Topitz A. Effect of lithium on the EEG of healthy males and females. Neuropsychobiology 1988; 20: 15863.
  • 388
    Bell AJ, Cole A, Eccleston D, Ferrier IN. Lithium neurotoxicity at normal therapeutic levels. Br J Psychiatry 1993; 162: 68992.
  • 389
    Devinsky O, Duchowny MS. Seizures after convulsive therapy: a retrospective case survey. Neurology 1983; 33: 9215.
  • 390
    Grogan R, Wagner DR, Sullivan T, Labar D. Generalised non-convulsive status epilepticus after electroconvulsive therapy. Convulsive Ther 1995; 11: 516.
  • 391
    Blumenthal IJ. Spontaneous seizures and related electroencephalographic findings following shock therapy. J Nerv Ment Dis 1955; 122: 5818.
  • 392
    Blackwood DHR, Cull RE, Freeman CPL, Evans JI, Maudsley C. A study of the incidence of epilepsy following ECT. J Neurol Neurosurg Psychiatry 1980; 43: 1098102.
  • 393
    Hsiao JK, Messenheimer JA, Evans DL. ECT and neurological disorders. Convulsive Ther 1987; 3: 12136.
  • 394
    Freeman CPL. ECT and other physical therapies. In: KendellRE, ZealleyAK, eds. Companion to psychiatric studies. 5th ed. Edinburgh : Churchill-Livingstone, 1993;84767.
  • 395
    Kalinowsky LB, Kennedy F. Observation in electroshock therapy applied to the problems of epilepsy. J Nerv Ment Dis 1943; 98: 5667.
  • 396
    Keller CH, Bernstein HJ. ECT as a treatment for neurologic illness. In: CoffeyCE, ed. The clinical science of electroconvulsive therapy. Washington , DC : American Psychiatric Press, 1993: 183210.
  • 397
    Krystal AD, Weiner RD. ECT seizure adequacy. Convulsive Ther 1993; 10: 15364.
  • 398
    Weiner RD, Coffey CE. Electroconvulsive therapy in the medical and neurologic patient. In: StoudemireA, FogelBS, eds. Psychiatric care of the medical patient. New York : Oxford University Press, 1993;20724.